Skip to main content
. 2016 Sep 27;11(9):e0163484. doi: 10.1371/journal.pone.0163484

Fig 2. Distribution of the modified Rankin Scale (mRS) scores among patients classified based on the use of alpha-lipoic acid (aLA) 3 months (A) and 1 year (B) after ischemic stroke.

Fig 2

The lines indicate differences in mRS categories (mRS scores of 0–2 vs. 3–6) between groups classified by aLA use. The p-value refers to the significance level of the chi-square test used to compare proportions.